Nuclear Medicine and Biology
Volume 35, Issue 1 , Pages 29-34, January 2008

A change of in vivo characteristics depending on specific activity of radioiodinated (+)-2-[4-(4-iodophenyl)piperidino]cyclohexanol [(+)-pIV] as a ligand for sigma receptor imaging

  • Nasima Akhter

      Affiliations

    • Department of Biotracer Medicine, Kanazawa University, Kanazawa 920-8640, Ishikawa, Japan
  • ,
  • Kazuhiro Shiba

      Affiliations

    • Division of Tracer Kinetics, Advanced Science Research Center, Kanazawa University, Kanazawa 920-8640, Ishikawa, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 76 265 2474; fax: +81 76 234 4245.
  • ,
  • Kazuma Ogawa

      Affiliations

    • Division of Tracer Kinetics, Advanced Science Research Center, Kanazawa University, Kanazawa 920-8640, Ishikawa, Japan
  • ,
  • Shiro Tsuji

      Affiliations

    • School of Health Sciences, Kanazawa University, Kanazawa 920-8640, Ishikawa, Japan
  • ,
  • Seigo Kinuya

      Affiliations

    • Department of Biotracer Medicine, Kanazawa University, Kanazawa 920-8640, Ishikawa, Japan
  • ,
  • Kenichi Nakajima

      Affiliations

    • Department of Biotracer Medicine, Kanazawa University, Kanazawa 920-8640, Ishikawa, Japan
  • ,
  • Hirofumi Mori

      Affiliations

    • Division of Tracer Kinetics, Advanced Science Research Center, Kanazawa University, Kanazawa 920-8640, Ishikawa, Japan

Received 9 August 2007; received in revised form 12 September 2007; accepted 27 September 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0969-8051(07)00244-2

doi:10.1016/j.nucmedbio.2007.09.005

Nuclear Medicine and Biology
Volume 35, Issue 1 , Pages 29-34, January 2008